OXFORD VACMEDIX
Oxford Vacmedix was established in 2012 as a spinout from Oxford University. Its aim is to develop therapeutic agents for the treatment of cancer based on the invention of Dr Shisong Jiang - Recombinant Overlapping Peptides (ROP). These agents are an exciting new way to deliver immunotherapy which is now a major focus in the treatment of cancer, making it easier to deliver, more effective and much more economical. Immunotherapy is effective by activating the immune system to attack tumours directly thus reducing the need for invasive treatments such as chemo and radiotherapy.
OXFORD VACMEDIX
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxfordvacmedix.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
12.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Ennar Pharma
Development of medicines for the treatment of psoriasis.
Current Employees Featured
Founder
Investors List
Cancer Rop
Cancer Rop investment in Series A - Oxford Vacmedix
Oxford University Innovation
Oxford University Innovation investment in Seed Round - Oxford Vacmedix
Official Site Inspections
http://www.oxfordvacmedix.com
- Host name: 92.205.145.103
- IP address: 92.205.145.103
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
